아이언우드 제약 (IRWD)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

아이언우드 제약 Stock (IRWD) Company Profile

Ironwood Pharmaceuticals Inc

Healthcare (1115)

617-621-7722

100 SUMMER STREET, SUITE 2300, BOSTON, MA

@ironwoodpharma

최신 SEC 제출 서류

IRWD's Discussions on Twitter

IRWD을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
IRWD Ironwood Pharmaceuticals Inc	4.50	735.31M	400.57M	9.21M	146.36M	0.04
ZTS Zoetis Inc	124.65	55.21B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	16.16	51.59B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.83	43.51B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	31.76	37.11B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	464.93	20.32B	3.08B	1.24B	1.07B	25.61

아이언우드 제약 Stock (IRWD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-01-05	업그레이드	Citizens JMP	Mkt Perform → Mkt Outperform
2025-04-15	다운그레이드	Jefferies	Buy → Hold
2025-04-15	다운그레이드	Wells Fargo	Overweight → Equal Weight
2025-04-14	다운그레이드	Citizens JMP	Mkt Outperform → Mkt Perform
2024-09-09	개시	Leerink Partners	Market Perform
2024-08-08	다운그레이드	CapitalOne	Overweight → Equal Weight
2024-01-17	개시	Craig Hallum	Buy
2023-12-14	개시	Wells Fargo	Overweight
2023-11-09	개시	Jefferies	Buy
2023-09-28	개시	JMP Securities	Mkt Outperform
2022-09-02	개시	CapitalOne	Overweight
2022-04-22	개시	Piper Sandler	Overweight
2020-09-30	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-06-17	개시	Northland Capital	Outperform
2019-07-10	재개	Credit Suisse	Neutral
2019-03-27	업그레이드	Morgan Stanley	Underweight → Equal-Weight
2019-02-25	업그레이드	H.C. Wainwright	Sell → Neutral
2019-01-24	업그레이드	JP Morgan	Underweight → Neutral
2018-11-07	다운그레이드	Credit Suisse	Outperform → Neutral
2018-11-07	다운그레이드	JP Morgan	Neutral → Underweight
2018-07-23	개시	H.C. Wainwright	Sell
2018-05-09	다운그레이드	Morgan Stanley	Equal-Weight → Underweight
2018-01-05	다운그레이드	BofA/Merrill	Buy → Underperform
2017-12-06	다운그레이드	Mizuho	Buy → Neutral
2017-07-21	다운그레이드	JP Morgan	Overweight → Neutral
2017-05-03	개시	Wells Fargo	Outperform
2017-04-07	재확인	Mizuho	Buy
2017-02-22	재확인	Barclays	Equal Weight
2016-11-04	재확인	Mizuho	Buy
2016-10-24	재확인	Wedbush	Neutral
2016-10-10	재확인	Mizuho	Buy
2016-09-27	재확인	WallachBeth	Hold

아이언우드 제약 주식(IRWD)의 최신 뉴스

아이언우드 제약 (IRWD) 재무 분석

아이언우드 제약 (IRWD)

아이언우드 제약 Stock (IRWD) Company Profile

IRWD을(를) 다른 주식과 비교

아이언우드 제약 Stock (IRWD) Upgrades & Downgrades

아이언우드 제약 주식(IRWD)의 최신 뉴스

Weekly Earnings: Is Ironwood Pharmaceuticals Inc forming a breakout patternJuly 2025 Short Interest & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Aug Weekly: Is Ironwood Pharmaceuticals Inc forming a breakout patternPortfolio Profit Report & Verified Technical Trade Signals - baoquankhu1.vn

Ironwood Pharma Stock Soars After FDA Grants Approval For Irritable Bowel Syndrome Drug In Pediatric Patients - MSN

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 5.4%Here's Why - MarketBeat

Insider Sell: Should you avoid Ironwood Pharmaceuticals Inc. stock right nowMarket Sentiment Review & Entry Point Strategy Guides - baoquankhu1.vn

Ironwood Pharmaceuticals (IRWD) Price Target Increased by 94.00% to 4.95 - Nasdaq

Growth Recap: Does Ironwood Pharmaceuticals Inc have declining or rising EPSWeekly Market Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 10.7%Here's What Happened - MarketBeat

Winners Losers: Is Ironwood Pharmaceuticals Inc affected by consumer sentimentJuly 2025 Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Published on: 2026-01-10 17:20:03 - Улправда

Ironwood Pharma resolves Ferring dispute, amends license terms - MSN

Ironwood stock rises 27% on upbeat revenue guidance for 2026 - MSN

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance

Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating - MarketBeat

5 Small Drug Stocks to Buy as Industry Recovery Picks Up - Yahoo Finance

Ironwood hits 52-week high as AbbVie-partnered Linzess boosts 2026 outlook - MSN

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Upgraded by Craig Hallum - MarketBeat

Why did Ironwood Pharmaceuticals stock skyrocket today? - MSN

There's No Escaping Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Muted Revenues Despite A 32% Share Price Rise - 富途牛牛

Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Shares Bounce 32% But Its Business Still Trails The Industry - simplywall.st

Citizens Upgrades Ironwood Pharmaceuticals (IRWD) - Nasdaq

Craig-Hallum Boosts Ironwood (IRWD) Rating with Optimistic Outlo - GuruFocus

Wells Fargo Raises Target Price for IRWD to $5.00 Maintaining Eq - GuruFocus

Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026 - Finviz

Wells Fargo & Company Forecasts Strong Price Appreciation for Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock - MarketBeat

Ironwood Pharmaceuticals Inc. (IRWD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

The Five-year Loss for Ironwood Pharmaceuticals (NASDAQ:IRWD) Shareholders Likely Driven by Its Shrinking Earnings - 富途牛牛

Ironwood Pharmaceuticals (IRWD) Upgraded to Market Outperform by Citizens | IRWD Stock News - GuruFocus

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Upgraded by Citizens Jmp - MarketBeat

Stock Market Today: S&P 500, Nasdaq, WTI Crude Futures Advance After US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus (UPDATED) - Benzinga

Ironwood Pharmaceuticals stock rises premarket after Citizens upgrade, Wells Fargo target lift - TechStock²

Ironwood Pharmaceuticals stock price target raised to $5 by Wells Fargo - Investing.com Canada

Citizens upgrades Ironwood Pharmaceuticals stock rating on LINZESS strength By Investing.com - Investing.com Canada

Promising Pharmaceutical Stocks To ConsiderJanuary 2nd - MarketBeat

Ironwood Pharmaceuticals Surges on Linzess Sales Boost - StocksToTrade

Ironwood Pharmaceuticals’ Stock Surges as Higher Linzess Sales Drive Market Excitement - timothysykes.com

Why Did Ironwood Pharmaceuticals Stock Skyrocket Today? - Asianet Newsable

Ironwood Pharma leaps on 2025/2026 guidance - The Pharma Letter

Ironwood backs FY25 revenue view $290M-$310M, consensus $306.97M - Yahoo Finance

Ironwood Pharmaceuticals (NASDAQ:IRWD) Rating Increased to Strong-Buy at Zacks Research - MarketBeat

Ironwood Pharmaceuticals: Market Response to Legal Settlement - StocksToTrade

Ironwood Pharma (IRWD) Surges on Strong FY26 Guidance and Pipeli - GuruFocus

Stock soars at Boston biotech after it cuts price of IBS drug - The Business Journals

Ironwood Pharmaceuticals Stock (IRWD) Opinions on 2026 Financial Guidance - Quiver Quantitative

Ironwood Pharmaceuticals Stock Soars as Drug-Price Cut Boosts Prospects for 2026 - Barron's

Ironwood Pharmaceuticals stock soars on strong 2026 guidance By Investing.com - Investing.com Nigeria

Ironwood Pharmaceuticals stock soars on strong 2026 guidance - Investing.com

Stock Traders Buy High Volume of Ironwood Pharmaceuticals Call Options (NASDAQ:IRWD) - MarketBeat

Ironwood boosts outlook on AbbVie's Linzess (update) (IRWD) - Seeking Alpha

아이언우드 제약 (IRWD) 재무 분석

매출

순이익

현금흐름

주당 순 이익

IRWD과 유사한 종목